123 related articles for article (PubMed ID: 29236960)
1. MicroRNA-128-3p-mediated depletion of Drosha promotes lung cancer cell migration.
Frixa T; Sacconi A; Cioce M; Roscilli G; Ferrara FF; Aurisicchio L; Pulito C; Telera S; Carosi M; Muti P; Strano S; Donzelli S; Blandino G
Carcinogenesis; 2018 Feb; 39(2):293-304. PubMed ID: 29236960
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C.
Chang TH; Tsai MF; Gow CH; Wu SG; Liu YN; Chang YL; Yu SL; Tsai HC; Lin SW; Chen YW; Kuo PY; Yang PC; Shih JY
Cancer Lett; 2017 Aug; 402():190-202. PubMed ID: 28610956
[TBL] [Abstract][Full Text] [Related]
3. DICER1, DROSHA and miRNAs in patients with non-small cell lung cancer: implications for outcomes and histologic classification.
Díaz-García CV; Agudo-López A; Pérez C; López-Martín JA; Rodríguez-Peralto JL; de Castro J; Cortijo A; Martínez-Villanueva M; Iglesias L; García-Carbonero R; Fresno Vara JA; Gámez-Pozo A; Palacios J; Cortés-Funes H; Paz-Ares L; Agulló-Ortuño MT
Carcinogenesis; 2013 May; 34(5):1031-8. PubMed ID: 23349018
[TBL] [Abstract][Full Text] [Related]
4. Dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p) coordinately targeted MTDH in lung squamous cell carcinoma.
Mataki H; Seki N; Mizuno K; Nohata N; Kamikawaji K; Kumamoto T; Koshizuka K; Goto Y; Inoue H
Oncotarget; 2016 Nov; 7(44):72084-72098. PubMed ID: 27765924
[TBL] [Abstract][Full Text] [Related]
5. miR-1236-3p suppresses the migration and invasion by targeting KLF8 in lung adenocarcinoma A549 cells.
Bian T; Jiang D; Liu J; Yuan X; Feng J; Li Q; Zhang Q; Li X; Liu Y; Zhang J
Biochem Biophys Res Commun; 2017 Oct; 492(3):461-467. PubMed ID: 28842254
[TBL] [Abstract][Full Text] [Related]
6. miRomics and Proteomics Reveal a miR-296-3p/PRKCA/FAK/Ras/c-Myc Feedback Loop Modulated by HDGF/DDX5/β-catenin Complex in Lung Adenocarcinoma.
Fu Q; Song X; Liu Z; Deng X; Luo R; Ge C; Li R; Li Z; Zhao M; Chen Y; Lin X; Zhang Q; Fang W
Clin Cancer Res; 2017 Oct; 23(20):6336-6350. PubMed ID: 28751441
[No Abstract] [Full Text] [Related]
7. Tumor suppressor miR-128-3p inhibits metastasis and epithelial-mesenchymal transition by targeting ZEB1 in esophageal squamous-cell cancer.
Zhao L; Li R; Xu S; Li Y; Zhao P; Dong W; Liu Z; Zhao Q; Tan B
Acta Biochim Biophys Sin (Shanghai); 2018 Feb; 50(2):171-180. PubMed ID: 29329360
[TBL] [Abstract][Full Text] [Related]
8. Unique microRNAs in lung adenocarcinoma groups according to major TKI sensitive EGFR mutation status.
Pak MG; Lee CH; Lee WJ; Shin DH; Roh MS
Diagn Pathol; 2015 Jul; 10():99. PubMed ID: 26170125
[TBL] [Abstract][Full Text] [Related]
9. Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer.
Rhodes LV; Martin EC; Segar HC; Miller DF; Buechlein A; Rusch DB; Nephew KP; Burow ME; Collins-Burow BM
Oncotarget; 2015 Jun; 6(18):16638-52. PubMed ID: 26062653
[TBL] [Abstract][Full Text] [Related]
10. MiR-182 inhibits the epithelial to mesenchymal transition and metastasis of lung cancer cells by targeting the Met gene.
Li Y; Zhang H; Li Y; Zhao C; Fan Y; Liu J; Li X; Liu H; Chen J
Mol Carcinog; 2018 Jan; 57(1):125-136. PubMed ID: 28940757
[TBL] [Abstract][Full Text] [Related]
11. miR-126-3p and miR-451a correlate with clinicopathological features of lung adenocarcinoma: The underlying molecular mechanisms.
Chen Q; Hu H; Jiao D; Yan J; Xu W; Tang X; Chen J; Wang J
Oncol Rep; 2016 Aug; 36(2):909-17. PubMed ID: 27277197
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of microRNA-183-3p is a potent prognostic marker for lung adenocarcinoma of female non-smokers.
Xu F; Zhang H; Su Y; Kong J; Yu H; Qian B
Clin Transl Oncol; 2014 Nov; 16(11):980-5. PubMed ID: 24805982
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA expression profiles and clinicopathological implications in lung adenocarcinoma according to EGFR, KRAS, and ALK status.
Kim H; Yang JM; Jin Y; Jheon S; Kim K; Lee CT; Chung JH; Paik JH
Oncotarget; 2017 Jan; 8(5):8484-8498. PubMed ID: 28035073
[TBL] [Abstract][Full Text] [Related]
14. MiRNA-125a-3p is a negative regulator of the RhoA-actomyosin pathway in A549 cells.
Huang B; Luo W; Sun L; Zhang Q; Jiang L; Chang J; Qiu X; Wang E
Int J Oncol; 2013 May; 42(5):1734-42. PubMed ID: 23525486
[TBL] [Abstract][Full Text] [Related]
15. TWIST1 upregulates miR-214 to promote epithelial-to-mesenchymal transition and metastasis in lung adenocarcinoma.
Liu C; Luo J; Zhao YT; Wang ZY; Zhou J; Huang S; Huang JN; Long HX; Zhu B
Int J Mol Med; 2018 Jul; 42(1):461-470. PubMed ID: 29693173
[TBL] [Abstract][Full Text] [Related]
16. Deregulated MicroRNAs in Cancer-Associated Fibroblasts from Front Tumor Tissues of Lung Adenocarcinoma as Potential Predictors of Tumor Promotion.
Negrete-Garcia MC; Ramírez-Rodriguez SL; Rangel-Escareño C; Muñoz-Montero S; Kelly-García J; Vázquez-Manríquez ME; Santillán P; Ramírez MM; Ramírez-Martínez G; Ramírez-Venegas A; Ortiz-Quintero B
Tohoku J Exp Med; 2018 Oct; 246(2):107-120. PubMed ID: 30369556
[TBL] [Abstract][Full Text] [Related]
17. Syndecan-1 up-regulates microRNA-331-3p and mediates epithelial-to-mesenchymal transition in prostate cancer.
Fujii T; Shimada K; Tatsumi Y; Tanaka N; Fujimoto K; Konishi N
Mol Carcinog; 2016 Sep; 55(9):1378-86. PubMed ID: 26259043
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of microRNA-95-3p suppresses brain metastasis of lung adenocarcinoma through downregulation of cyclin D1.
Hwang SJ; Lee HW; Kim HR; Song HJ; Lee DH; Lee H; Shin CH; Joung JG; Kim DH; Joo KM; Kim HH
Oncotarget; 2015 Aug; 6(24):20434-48. PubMed ID: 25971210
[TBL] [Abstract][Full Text] [Related]
19. [MiR-373-3p Promotes Invasion and Metastasis of Lung Adenocarcinoma Cells].
Wu A; Li J; Wu K; Mo Y; Luo Y; Ye H; Shen X; Li S; Liang Y; Liu M; Yang Z
Zhongguo Fei Ai Za Zhi; 2015 Jul; 18(7):427-35. PubMed ID: 26182868
[TBL] [Abstract][Full Text] [Related]
20. The microRNA-processing enzymes: Drosha and Dicer can predict prognosis of nasopharyngeal carcinoma.
Guo X; Liao Q; Chen P; Li X; Xiong W; Ma J; Li X; Luo Z; Tang H; Deng M; Zheng Y; Wang R; Zhang W; Li G
J Cancer Res Clin Oncol; 2012 Jan; 138(1):49-56. PubMed ID: 21953080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]